Skip to main content

Table 2 Cumulative incidence rate of death factors in patients with prostate cancer by Gray’s test

From: Competing risk of the specific mortality among Asian-American patients with prostate cancer: a surveillance, epidemiology, and end results analysis

Variables

P

CIF

95%CI

Lower

Upper

Race

    

 Ethnic Chinese

0.021

5.96

4.86

7.20

 Other Asian-Americans

 

7.42

6.76

8.11

Age at diagnosis

    

 < 65

< 0.001

4.90

4.12

5.76

 ≥ 65

 

8.52

7.74

9.35

Marital status

    

 Married

< 0.001

6.67

6.02

7.35

 Unmarried, single or widowed

 

8.72

7.47

10.08

Grade

    

 I

< 0.001

3.07

2.39

3.89

 II

 

10.26

9.41

11.15

T stage

    

 T1

< 0.001

6.63

5.69

7.67

 T2

 

6.00

5.27

6.80

 T3

 

10.95

8.89

13.25

 T4

 

37.28

30.01

44.54

N stage

    

 N0

< 0.001

6.48

5.91

7.08

 N1

 

40.22

33.84

46.51

M stage

    

 M0

< 0.001

5.67

5.13

6.24

 M1

 

65.17

51.15

78.37

Radiotherapy

    

 No

< 0.001

6.92

6.34

7.53

 Yes

 

13.21

9.73

17.22

Chemotherapy

    

 No

< 0.001

7.00

6.42

7.61

 Yes

 

31.66

21.04

42.79

Surgery

    

 No

< 0.001

9.01

8.17

9.91

 Yes

 

4.25

3.67

4.89

Regional nodes positive

    

 No

< 0.001

3.02

2.29

3.89

 Yes

 

8.25

7.55

8.99

Histological types

    

 Adenocarcinoma

0.611

7.20

6.61

7.83

 Squamous-cell carcinoma, mucinous carcinoma or sarcoma

 

6.00

3.68

9.10

  1. CIF cumulative incidence function, CI confidence interval